SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study

TEL AVIV, Israel, July 13, 2022 -- (Healthcare Sales & Marketing Network) -- SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that on M... Devices SoniVie , TIVS System, Intra-Vascular Ultrasound, renal denervation

https://salesandmarketingnetwork.com/news_release_bs.html?ID=2047665

Source: HSMN NewsFeed - July 13, 2022 Category: Pharmaceuticals Source Type: news